Clinical Trial

Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

Study acronym: rTMS for CIPN
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate the change in pain scores among patients with chemotherapy-induced peripheral neuropathy after receiving treatment with repetitive transcranial magnetic stimulation (rTMS).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-08-05; most recent amendment 2026-05-29.
Status change: Not Yet Recruiting → Recruiting 2025-09-08
Trial Details
NCT Number NCT07120100
Lead Sponsor University of Utah
Conditions Breast Cancer Female, Gynecologic Cancer
Enrollment 19 participants
Start Date 2025-08-27
Primary Completion 2027-09-15 (estimated)
Study Completion 2028-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-02